| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |